SCHEMBL9201193

SCHEMBL9201193

CCCCN(c1ccncc1F)N1CC(Cc2ccccc2)c2cc(C)ccc21

nearest known ligand 0.36

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.36
CYP46A1 Q9Y6A2 2/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
UBE2M P61081 1/20 0.31
DCUN1D1 Q96GG9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13663906 0.72 BCHE (0.37) BCHE
SCHEMBL9198258 0.70 KMT2A (0.31) KMT2A
SCHEMBL9210052 0.68 KDM4C (0.33) MEN1KMT2A
SCHEMBL7610193 0.59 SLC6A2 (0.66) BCHE
SCHEMBL7609242 0.59 BCHE (0.42) BCHE
SCHEMBL9665183 0.59 SLC6A2 (0.62) BCHE
Hydrochloric Acid SCHEMBL7643682 0.58 BCHE (0.41) BCHE
SCHEMBL8860332 0.57 BCHE (0.38) BCHE
SCHEMBL9381929 0.57 BCHE (0.41) BCHE
Nerispirdine SCHEMBL3842518 0.57 SLC6A2 (0.67) BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0415103-B1 2,3-Dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1995-02-01 EP disclosed
US-5296488-A Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-03-22 US disclosed
US-5179099-A Analgesics HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-01-12 US disclosed
EP-0415103-A1 2,3-Dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-03-06 EP disclosed